Tissue Regenix: £25m funding allows firm to independently expand
This article was originally published in Clinica
Executive Summary
Regenerative medicine specialist Tissue Regenix has raised £25m ($39.3m) in a share placement to fund the further development of its dCELL vascular patch and other products.